Ethical considerations for psychedelic-assisted therapy in military clinical settings
Journal of Medical Ethics May 30, 2023 Scott Hoener, Aaron Wolfgang, David A. Nissan et al. 6 citations
Psychedelic treatments, particularly 3,4-methylenedioxymethamphetamine (MDMA)-assisted and psilocybin-assisted therapies, have recently seen renewed interest in their clinical potential to treat various mental health conditions. Clinical trials for both MDMA-assisted and psilocybin-assisted therapies have shown to be highly efficacious for post-traumatic stress disorder and major depression....